Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation
被引:94
作者:
Baeckdahl, Liselotte
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Inst Canc, Med Genom Grp, London WC1E 6BT, EnglandUCL, Inst Canc, Med Genom Grp, London WC1E 6BT, England
Baeckdahl, Liselotte
[1
]
Bushell, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, EnglandUCL, Inst Canc, Med Genom Grp, London WC1E 6BT, England
Bushell, Andrew
[2
]
Beck, Stephan
论文数: 0引用数: 0
h-index: 0
机构:
UCL, Inst Canc, Med Genom Grp, London WC1E 6BT, EnglandUCL, Inst Canc, Med Genom Grp, London WC1E 6BT, England
Beck, Stephan
[1
]
机构:
[1] UCL, Inst Canc, Med Genom Grp, London WC1E 6BT, England
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England
Recent Successes of therapeutic intervention in chronic inflammatory diseases using epigenetic modifiers Such as historic deacetylase inhibitors and inhibitors of DNA methylation Suggest that epigenetic reprogramming plays a role in the aetiology of these diseases. The epigenetic signature of a given immune cell is reflected in the history of modifications from different signals the cell has been subjected to during differentiation. Like other cells, differentiating immune cells are dependent on a complex combination of inter- and intracell signalling as well as transcription machineries to modulate their epigenomes ill order to mediate differentiation. Despite extensive research into these processes, the link between cellular signalling and epigenetic modulation remains poorly understood. Here, we review recent progress and discuss key factors driving epigenetic modulation in chronic inflammation. (C) 2008 Elsevier Ltd. All rights reserved.